| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antigens, Nuclear | 8 | 2013 | 126 | 1.150 |
Why?
|
| Cellular Senescence | 8 | 2013 | 388 | 1.140 |
Why?
|
| DNA Ligases | 6 | 2013 | 67 | 0.900 |
Why?
|
| DNA-Binding Proteins | 16 | 2013 | 5000 | 0.820 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 7 | 2009 | 67 | 0.740 |
Why?
|
| Insulin-Secreting Cells | 2 | 2013 | 160 | 0.730 |
Why?
|
| Tumor Suppressor Protein p53 | 13 | 2014 | 3653 | 0.700 |
Why?
|
| Recombination, Genetic | 10 | 2009 | 665 | 0.620 |
Why?
|
| DNA Damage | 10 | 2013 | 1981 | 0.610 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2009 | 327 | 0.530 |
Why?
|
| DNA End-Joining Repair | 2 | 2013 | 92 | 0.520 |
Why?
|
| DNA Repair | 9 | 2008 | 1910 | 0.430 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2011 | 1900 | 0.390 |
Why?
|
| Ultraviolet Rays | 2 | 2011 | 588 | 0.380 |
Why?
|
| DNA Ligase ATP | 6 | 2013 | 53 | 0.360 |
Why?
|
| VDJ Exons | 1 | 2009 | 7 | 0.350 |
Why?
|
| Radiation Tolerance | 4 | 2011 | 637 | 0.340 |
Why?
|
| Cell Cycle Proteins | 5 | 2011 | 2116 | 0.330 |
Why?
|
| beta Catenin | 1 | 2013 | 681 | 0.320 |
Why?
|
| Homeostasis | 2 | 2013 | 923 | 0.320 |
Why?
|
| Immune Tolerance | 1 | 2010 | 423 | 0.300 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2009 | 217 | 0.300 |
Why?
|
| Ku Autoantigen | 8 | 2013 | 82 | 0.300 |
Why?
|
| B-Lymphocytes | 6 | 2013 | 1423 | 0.290 |
Why?
|
| Thymus Gland | 8 | 2006 | 311 | 0.280 |
Why?
|
| Gene Targeting | 2 | 2006 | 314 | 0.280 |
Why?
|
| Mice, SCID | 9 | 2002 | 1826 | 0.270 |
Why?
|
| Receptors, Antigen, B-Cell | 1 | 2008 | 174 | 0.270 |
Why?
|
| DNA Helicases | 6 | 1999 | 450 | 0.270 |
Why?
|
| Genes, Lethal | 1 | 2006 | 131 | 0.260 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 4 | 2009 | 185 | 0.260 |
Why?
|
| Mice | 30 | 2014 | 35465 | 0.240 |
Why?
|
| Cell Cycle | 3 | 2009 | 2136 | 0.240 |
Why?
|
| Embryo, Mammalian | 2 | 2006 | 744 | 0.220 |
Why?
|
| Nucleic Acid Conformation | 4 | 1996 | 307 | 0.210 |
Why?
|
| Animals | 32 | 2014 | 61714 | 0.200 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 4 | 2011 | 437 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2011 | 1415 | 0.180 |
Why?
|
| Physarum | 2 | 1990 | 3 | 0.180 |
Why?
|
| Apoptosis | 7 | 2014 | 7741 | 0.180 |
Why?
|
| Genes, myc | 1 | 2002 | 372 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 2013 | 537 | 0.180 |
Why?
|
| DNA Nucleotidyltransferases | 2 | 2002 | 32 | 0.180 |
Why?
|
| Lymphoma | 2 | 2011 | 1517 | 0.180 |
Why?
|
| Polyamines | 2 | 1990 | 80 | 0.170 |
Why?
|
| Gene Amplification | 1 | 2002 | 766 | 0.170 |
Why?
|
| Nuclear Proteins | 8 | 2002 | 3437 | 0.160 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 3 | 2008 | 47 | 0.150 |
Why?
|
| Gene Rearrangement | 4 | 1998 | 812 | 0.150 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 3699 | 0.150 |
Why?
|
| Radiation Chimera | 1 | 1996 | 32 | 0.140 |
Why?
|
| Severe Combined Immunodeficiency | 2 | 1998 | 111 | 0.140 |
Why?
|
| Blood Glucose | 2 | 2013 | 1260 | 0.140 |
Why?
|
| Translocation, Genetic | 1 | 2002 | 1285 | 0.140 |
Why?
|
| Gamma Rays | 2 | 1996 | 237 | 0.140 |
Why?
|
| Genes, Immunoglobulin | 1 | 1996 | 85 | 0.130 |
Why?
|
| Mice, Knockout | 10 | 2014 | 5694 | 0.130 |
Why?
|
| Insulin | 2 | 2013 | 1471 | 0.130 |
Why?
|
| Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 1995 | 3 | 0.130 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 2 | 1997 | 172 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2013 | 840 | 0.120 |
Why?
|
| Adenocarcinoma | 1 | 2013 | 7883 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2007 | 7343 | 0.120 |
Why?
|
| Lymphocytes | 4 | 2009 | 1272 | 0.120 |
Why?
|
| Mice, Inbred C57BL | 7 | 2014 | 7038 | 0.110 |
Why?
|
| Ubiquitin-Specific Proteases | 1 | 2014 | 71 | 0.110 |
Why?
|
| NFATC Transcription Factors | 1 | 2014 | 96 | 0.110 |
Why?
|
| Phenotype | 7 | 2011 | 6485 | 0.110 |
Why?
|
| Ubiquitination | 2 | 2014 | 579 | 0.110 |
Why?
|
| Telomere | 2 | 2011 | 548 | 0.110 |
Why?
|
| S-Adenosylmethionine | 2 | 1990 | 43 | 0.110 |
Why?
|
| Fibroblasts | 7 | 2013 | 1628 | 0.110 |
Why?
|
| TNF Receptor-Associated Factor 3 | 1 | 2013 | 22 | 0.110 |
Why?
|
| Base Sequence | 9 | 2006 | 5424 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 7 | 2006 | 3468 | 0.110 |
Why?
|
| T-Lymphocytes | 6 | 2013 | 3939 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 1996 | 1135 | 0.110 |
Why?
|
| Th1 Cells | 1 | 2014 | 259 | 0.100 |
Why?
|
| Homeodomain Proteins | 3 | 2009 | 1120 | 0.100 |
Why?
|
| VDJ Recombinases | 3 | 2003 | 14 | 0.100 |
Why?
|
| Blotting, Western | 3 | 2007 | 3588 | 0.100 |
Why?
|
| Restriction Mapping | 2 | 2006 | 330 | 0.100 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor Proteins | 1 | 2011 | 24 | 0.100 |
Why?
|
| T-Lymphocyte Subsets | 1 | 1995 | 594 | 0.100 |
Why?
|
| Endopeptidases | 1 | 2013 | 231 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2013 | 7236 | 0.100 |
Why?
|
| Homozygote | 3 | 2006 | 772 | 0.090 |
Why?
|
| Lymphoma, B-Cell | 3 | 2011 | 928 | 0.090 |
Why?
|
| Cyclin D1 | 1 | 2013 | 589 | 0.090 |
Why?
|
| Molecular Sequence Data | 8 | 2002 | 6674 | 0.090 |
Why?
|
| Photosensitivity Disorders | 1 | 2010 | 22 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2014 | 526 | 0.090 |
Why?
|
| Wnt Signaling Pathway | 1 | 2013 | 445 | 0.090 |
Why?
|
| Germ-Line Mutation | 1 | 1996 | 1101 | 0.090 |
Why?
|
| Acanthamoeba | 1 | 1989 | 17 | 0.090 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2011 | 223 | 0.090 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2011 | 320 | 0.090 |
Why?
|
| DNA, Fungal | 1 | 1990 | 144 | 0.090 |
Why?
|
| Cyclins | 1 | 2011 | 467 | 0.080 |
Why?
|
| Colon | 1 | 2013 | 653 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2007 | 2308 | 0.080 |
Why?
|
| Mutation | 7 | 2010 | 15900 | 0.080 |
Why?
|
| Haploinsufficiency | 1 | 2011 | 301 | 0.080 |
Why?
|
| Cells, Cultured | 3 | 2013 | 5658 | 0.080 |
Why?
|
| Glucose Intolerance | 1 | 2009 | 86 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 559 | 0.080 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2007 | 436 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2013 | 1042 | 0.080 |
Why?
|
| Islets of Langerhans | 1 | 2009 | 236 | 0.080 |
Why?
|
| Mice, Transgenic | 3 | 2013 | 4210 | 0.080 |
Why?
|
| Hypersensitivity | 1 | 2010 | 220 | 0.080 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2008 | 52 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 1570 | 0.070 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 622 | 0.070 |
Why?
|
| Genetic Loci | 1 | 2009 | 501 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 7632 | 0.070 |
Why?
|
| Crosses, Genetic | 1 | 2007 | 251 | 0.070 |
Why?
|
| Carcinogenesis | 1 | 2013 | 1035 | 0.070 |
Why?
|
| Genomic Instability | 1 | 2009 | 520 | 0.070 |
Why?
|
| Sister Chromatid Exchange | 1 | 2006 | 45 | 0.070 |
Why?
|
| DNA | 5 | 1996 | 3046 | 0.070 |
Why?
|
| Genes, p53 | 1 | 2011 | 1140 | 0.070 |
Why?
|
| Epithelial Cells | 1 | 2013 | 1867 | 0.070 |
Why?
|
| Cell Line | 3 | 2010 | 5336 | 0.070 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2006 | 117 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2013 | 1560 | 0.070 |
Why?
|
| Blotting, Southern | 1 | 2006 | 451 | 0.070 |
Why?
|
| Pancreas | 1 | 2009 | 744 | 0.060 |
Why?
|
| Electroporation | 1 | 2006 | 127 | 0.060 |
Why?
|
| Cytogenetic Analysis | 1 | 2007 | 574 | 0.060 |
Why?
|
| Xenopus Proteins | 1 | 2006 | 193 | 0.060 |
Why?
|
| Endodeoxyribonucleases | 1 | 2005 | 116 | 0.060 |
Why?
|
| Immunity, Innate | 1 | 2009 | 700 | 0.060 |
Why?
|
| Radiation, Ionizing | 3 | 2000 | 190 | 0.060 |
Why?
|
| Stem Cells | 4 | 2006 | 1211 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 651 | 0.060 |
Why?
|
| Skin | 1 | 2010 | 1270 | 0.060 |
Why?
|
| Chromosomes | 2 | 2002 | 324 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1542 | 0.060 |
Why?
|
| Models, Genetic | 5 | 2005 | 1163 | 0.050 |
Why?
|
| Antigens, CD | 2 | 2002 | 1411 | 0.050 |
Why?
|
| Cell Differentiation | 5 | 2014 | 4104 | 0.050 |
Why?
|
| Genes, RAG-1 | 1 | 2002 | 2 | 0.050 |
Why?
|
| HeLa Cells | 1 | 2006 | 1685 | 0.050 |
Why?
|
| Exons | 1 | 2006 | 1381 | 0.050 |
Why?
|
| DNA-Activated Protein Kinase | 3 | 1998 | 76 | 0.050 |
Why?
|
| Histones | 1 | 2009 | 1512 | 0.050 |
Why?
|
| DNA Replication | 1 | 2006 | 771 | 0.050 |
Why?
|
| RNA Interference | 1 | 2006 | 1385 | 0.050 |
Why?
|
| DNA Primers | 3 | 2006 | 1494 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2009 | 4939 | 0.050 |
Why?
|
| Neoplasms | 1 | 2007 | 15902 | 0.050 |
Why?
|
| beta-Lactamases | 1 | 2002 | 223 | 0.040 |
Why?
|
| Fetal Death | 1 | 2000 | 133 | 0.040 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 1 | 1998 | 40 | 0.040 |
Why?
|
| Lymphocyte Subsets | 1 | 1998 | 138 | 0.040 |
Why?
|
| Neurons | 2 | 2000 | 2453 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1990 | 589 | 0.040 |
Why?
|
| Heterozygote | 2 | 2005 | 1055 | 0.040 |
Why?
|
| Humans | 9 | 2014 | 270033 | 0.040 |
Why?
|
| Adenine | 2 | 1990 | 668 | 0.030 |
Why?
|
| Central Nervous System | 1 | 1998 | 453 | 0.030 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1995 | 15 | 0.030 |
Why?
|
| Models, Immunological | 1 | 1995 | 79 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 631 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 2 | 1996 | 2452 | 0.030 |
Why?
|
| Leupeptins | 1 | 2014 | 71 | 0.030 |
Why?
|
| Listeriosis | 1 | 2014 | 43 | 0.030 |
Why?
|
| Listeria monocytogenes | 1 | 2014 | 61 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2014 | 354 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2009 | 12087 | 0.030 |
Why?
|
| Pregnancy | 1 | 2006 | 8107 | 0.030 |
Why?
|
| Lymphocyte Activation | 2 | 2014 | 1717 | 0.030 |
Why?
|
| Cell Survival | 2 | 2014 | 3056 | 0.030 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1992 | 12 | 0.030 |
Why?
|
| Tumor Escape | 1 | 2014 | 247 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2002 | 6368 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 5773 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 431 | 0.020 |
Why?
|
| Melanoma, Experimental | 1 | 2014 | 382 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 159 | 0.020 |
Why?
|
| Protein Phosphatase 2C | 1 | 2011 | 86 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 1992 | 234 | 0.020 |
Why?
|
| Proteolysis | 1 | 2013 | 377 | 0.020 |
Why?
|
| Spermidine | 1 | 1990 | 9 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 1 | 1990 | 161 | 0.020 |
Why?
|
| Putrescine | 1 | 1990 | 18 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 269 | 0.020 |
Why?
|
| Carbon Radioisotopes | 1 | 1990 | 124 | 0.020 |
Why?
|
| Chromosomal Instability | 1 | 2011 | 229 | 0.020 |
Why?
|
| Dansyl Compounds | 1 | 1989 | 6 | 0.020 |
Why?
|
| Methionine | 1 | 1990 | 170 | 0.020 |
Why?
|
| Chromosome Aberrations | 2 | 2011 | 2031 | 0.020 |
Why?
|
| Cytosine | 1 | 1990 | 155 | 0.020 |
Why?
|
| Germ Cells | 1 | 2011 | 329 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 904 | 0.020 |
Why?
|
| Spleen | 1 | 2011 | 724 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 1461 | 0.020 |
Why?
|
| Methylation | 1 | 1990 | 624 | 0.020 |
Why?
|
| Immunoglobulin Joining Region | 2 | 1998 | 16 | 0.020 |
Why?
|
| Intestines | 1 | 2013 | 720 | 0.020 |
Why?
|
| Bacteria | 1 | 2013 | 653 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2011 | 482 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 1099 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 2003 | 3037 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2002 | 9039 | 0.020 |
Why?
|
| Female | 5 | 2013 | 148486 | 0.020 |
Why?
|
| Exodeoxyribonucleases | 1 | 2005 | 109 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 701 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2005 | 936 | 0.010 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2006 | 256 | 0.010 |
Why?
|
| Leukosialin | 1 | 2002 | 16 | 0.010 |
Why?
|
| Mitosis | 1 | 2005 | 680 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1997 | 5434 | 0.010 |
Why?
|
| Sialoglycoproteins | 1 | 2002 | 149 | 0.010 |
Why?
|
| Models, Biological | 1 | 2011 | 3187 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 2448 | 0.010 |
Why?
|
| CD4 Antigens | 1 | 2002 | 169 | 0.010 |
Why?
|
| Genotype | 2 | 2000 | 4249 | 0.010 |
Why?
|
| Endonucleases | 1 | 2002 | 184 | 0.010 |
Why?
|
| Cytokines | 1 | 2011 | 2810 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2006 | 1001 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2000 | 205 | 0.010 |
Why?
|
| Time Factors | 2 | 2005 | 12953 | 0.010 |
Why?
|
| Alleles | 1 | 2005 | 2590 | 0.010 |
Why?
|
| Male | 5 | 2013 | 127917 | 0.010 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2000 | 751 | 0.010 |
Why?
|
| Genes, Essential | 1 | 1998 | 57 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 14832 | 0.010 |
Why?
|
| Growth | 1 | 1999 | 125 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1998 | 227 | 0.010 |
Why?
|
| Body Patterning | 1 | 1998 | 208 | 0.010 |
Why?
|
| Nervous System | 1 | 1999 | 183 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2000 | 506 | 0.010 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 1997 | 56 | 0.010 |
Why?
|
| Kinetics | 1 | 2000 | 2186 | 0.010 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1996 | 7 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 3602 | 0.010 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1997 | 240 | 0.010 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1996 | 36 | 0.010 |
Why?
|
| Cell Division | 1 | 2000 | 2651 | 0.010 |
Why?
|
| Fetal Growth Retardation | 1 | 1997 | 232 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2000 | 1473 | 0.010 |
Why?
|
| CD3 Complex | 1 | 1996 | 320 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2000 | 1711 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1995 | 579 | 0.010 |
Why?
|
| Deoxyribonucleoproteins | 1 | 1993 | 5 | 0.010 |
Why?
|
| Bone Marrow Cells | 1 | 1997 | 965 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1995 | 606 | 0.010 |
Why?
|
| Thymus Neoplasms | 1 | 1997 | 416 | 0.010 |
Why?
|
| CD11 Antigens | 1 | 1992 | 20 | 0.010 |
Why?
|
| CD18 Antigens | 1 | 1992 | 73 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2000 | 2100 | 0.010 |
Why?
|
| Codon | 1 | 1992 | 261 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 416 | 0.010 |
Why?
|
| Binding Sites | 1 | 1995 | 2248 | 0.010 |
Why?
|
| Proteins | 1 | 1999 | 2043 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1992 | 1119 | 0.010 |
Why?
|
| Pedigree | 1 | 1992 | 2043 | 0.000 |
Why?
|
| Child | 1 | 1992 | 30466 | 0.000 |
Why?
|